Overview Science Safety Legal Therapy Checklist Dosage

Legal Status of Psychedelics (2026)

All classic psychedelics (psilocybin, LSD, DMT, mescaline) remain Schedule I under U.S. federal law — highest restriction, no accepted medical use. However, state and local reforms have created pockets of decriminalization and regulated therapeutic access. This is a rapidly changing area.

United States — Key Developments

  • Federal: Still Schedule I. 2026 Trump Executive Order accelerated FDA review and created priority pathways for psilocybin and ibogaine research.
  • Oregon: First regulated adult-use psilocybin services program (Measure 109/110 framework). Licensed service centers only; personal possession outside centers remains restricted.
  • Colorado: Natural Medicine program (Prop 122). Personal cultivation/possession + licensed healing centers for supervised use.
  • New Mexico: Medical Psilocybin Act passed; regulated access program targeted for late 2026 / 2027 launch.
  • Decriminalization cities: Denver, Oakland, Seattle, Washington D.C., and others have made enforcement lowest priority for personal amounts. King County, WA added deprioritization in 2026.
  • Other states: 18+ states had active legislation in 2025–2026. New Jersey launched a hospital-based pilot program (2026).

Canada

Federal prohibition remains, but Health Canada has expanded special access and clinical trial pathways. Alberta has a regulated framework for psilocybin/MDMA therapy under psychiatrist supervision. Some cities (Toronto, Vancouver) have reduced enforcement priorities.

International & Other Notes

  • Australia: Some psychedelics rescheduled for limited medical use (2023 onward, expanded).
  • Switzerland: Long-running limited medical use program (MDMA, LSD, psilocybin) with hundreds of patients treated annually.
  • Jamaica, Netherlands (truffles), Portugal: More permissive approaches in specific contexts.
  • Many countries still treat these as strictly controlled substances.
Critical: This is not legal advice. Possession, cultivation, or distribution remains illegal in most U.S. jurisdictions and can carry serious criminal penalties. Therapeutic access, where available, is tightly regulated. Always verify with current official sources (state health departments, DEA, local ordinances) before any activity.

Trusted resources: Johns Hopkins Center for Psychedelic Research · MAPS · UC Berkeley Center for the Science of Psychedelics · DanceSafe · Zendo Project · Fireside Project

Disclaimer: Cybinly provides this educational content for informational and harm-reduction purposes only. It is not medical, legal, or therapeutic advice. Psychedelic substances remain Schedule I under U.S. federal law and are illegal in most jurisdictions. Laws are rapidly evolving—always verify current regulations with official sources. Consult qualified healthcare professionals before considering any substance. If you or someone you know is in crisis, contact the Fireside Project at (623) 473-7433 or firesideproject.org.

Content reflects research and policy as of mid-2026. Last major update: 2026.